Maximizing mutagenesis with solubilized CRISPR Cas9 ribonucleoprotein complexes
CRISPR Cas9 enables efficient sequence specific mutagenesis for creating somatic or germline mutants of model organisms. Key constraints in vivo remain the expression and delivery of active Cas9 sgRNA ribonucleoprotein complexes (RNPs) with minimal toxicity, variable mutagenesis efficiencies depending on targeting sequence, and high mutation mosaicism. Here, we apply in vitro assembled, fluorescent Cas9 sgRNA RNPs in solubilizing salt solution to achieve maximal mutagenesis efficiency in zebrafish embryos. MiSeq based sequence analysis of targeted loci in individual embryos using CrispRVariants, a customized software tool for mutagenesis quantification and visualization, reveals efficient bi allelic mutagenesis that reaches saturation at several tested gene loci. Such virtually complete mutagenesis exposes loss of function phenotypes for candidate genes in somatic mutant embryos for subsequent generation of stable germline mutants. We further show that targeting of non coding elements in gene regulatory regions using saturating mutagenesis uncovers functional control elements in transgenic reporters and endogenous genes in injected embryos. Our results establish that optimally solubilized, in vitro assembled fluorescent Cas9 sgRNA RNPs provide a reproducible reagent for direct and scalable loss of function studies and applications beyond zebrafish experiments that require maximal DNA cutting efficiency in vivo. Summary: Maximal mutagenesis efficiency is achieved in vivo in zebrafish embryos using salt solubilized, fluorescently labelled Cas9 sgRNA complexes.
Development